Silence Therapeutics plc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
SLNCF Over the counter 8731 https://www.silence-therapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Silence Therapeutics plc

Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains? - Apr 12th, 2024 12:21 pm
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024 - Apr 11th, 2024 4:24 pm
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a) - Apr 8th, 2024 3:48 pm
Analysts Are Upgrading Silence Therapeutics plc (NASDAQ:SLN) After Its Latest Results - Mar 16th, 2024 12:29 pm
Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript - Mar 15th, 2024 3:56 pm
Silence Therapeutics Full Year 2023 Earnings: Misses Expectations - Mar 14th, 2024 11:14 am
Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights - Mar 13th, 2024 11:05 am
Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a) - Mar 13th, 2024 11:00 am
MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last? - Mar 6th, 2024 1:46 pm
Silence Therapeutics PLC Sponsored ADR (SLN) Soars 6.4%: Is Further Upside Left in the Stock? - Feb 28th, 2024 1:29 pm
Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024 - Feb 28th, 2024 1:00 pm
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial - Feb 23rd, 2024 1:00 pm
Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains? - Feb 16th, 2024 7:53 am
Broker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging Higher - Feb 7th, 2024 1:04 pm
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement - Feb 5th, 2024 1:00 pm
Strength Seen in Silence Therapeutics PLC Sponsored ADR (SLN): Can Its 15.4% Jump Turn into More Strength? - Feb 1st, 2024 1:19 pm
Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - Jan 31st, 2024 12:00 pm
Insiders the biggest winners as Silence Therapeutics plc's (NASDAQ:SLN) market cap rises to US$736m - Jan 20th, 2024 1:39 pm
All You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong Buy - Jan 11th, 2024 5:00 pm
Silence Therapeutics PLC Sponsored ADR (SLN) Is a Great Choice for 'Trend' Investors, Here's Why - Jan 5th, 2024 1:50 pm